Objective The purpose of the trial is to compare upper GI symptoms and endoscopy findings in Canada with Japan and Iran, and correlate this with the upper GI microbiome.
The primary outcomes is the bacterial microbiome in patients with FD compared to control patients without upper GI symptoms and a